| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 06/23/2011 | US20110150859 method for selecting responders to blockade of integrin receptors |
| 06/23/2011 | US20110150843 Method for the therapeutic correction of hemophilia a by transplanting bone marrow cells |
| 06/23/2011 | US20110150763 Triazine derivatives and their therapeutical applications |
| 06/23/2011 | CA2784500A1 Anti-thrombosis aptamers and method for stabilizing the structure thereof |
| 06/23/2011 | CA2782815A1 Decellularized adipose tissue |
| 06/23/2011 | CA2782601A1 Novel antiplatelet agent |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336165A1 Peptides and compounds that bind to the thrombopoietin receptor |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | EP2336109A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 06/22/2011 | EP2335719A1 Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism |
| 06/22/2011 | EP2335708A1 Sulphated glycosaminoglycans, including heparin and derivatives thereof, for use in inhibiting the expression of hepcidin and for the therapeutic treatment of anaemia with high levels of hepcidin |
| 06/22/2011 | EP2335494A1 Method for concentrating lipid |
| 06/22/2011 | EP2334667A1 A process for preparation of rosuvastatin acetonide calcium |
| 06/22/2011 | EP1866318B1 Thienopyridine compounds, and methods of use thereof |
| 06/22/2011 | EP1748985B1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 06/22/2011 | EP1668021B1 Novel thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics |
| 06/22/2011 | EP1660115B1 Pharmaceutical combination of g-csf and plgf useful for blood stem cell |
| 06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 06/22/2011 | CN102105453A Therapeutic agent for chronic renal failure |
| 06/22/2011 | CN102105161A Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 06/22/2011 | CN102105142A Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| 06/22/2011 | CN102105141A Method of producing thrombin-immobilized bioabsorbable sheet preparation |
| 06/22/2011 | CN102101884A Preparation method and use of donkey-hide gelatin polypeptide |
| 06/22/2011 | CN102100899A Preparation technology of new integrative formulation of prepared common monkshood daughter root decoction for regulating middle |
| 06/22/2011 | CN102100898A Preparation technology of new integrative formulation of pinellia decoction for purging stomach fire and production method thereof |
| 06/22/2011 | CN102100892A Preparation technology and production method of integrated Xiaojianzhong decoction novel dosage form |
| 06/22/2011 | CN102100891A Preparation technology and production method of new integrative formulation of true warrior decoction |
| 06/22/2011 | CN102100889A Preparation technology of new integrative formulation of spleen-returning decoction |
| 06/22/2011 | CN102100887A Preparation technology of new integrative formulation of kudzuvine root decoction and preparation method thereof |
| 06/22/2011 | CN102100886A Technology and method for preparing novel combined formulation of relieving-edema decoction |
| 06/22/2011 | CN102100843A Chinese medicine composition for treating virgin metrorrhagia and metrostaxis and using method thereof |
| 06/22/2011 | CN102100824A Traditional Chinese medicine for treating difficult urination |
| 06/22/2011 | CN102100813A Preparation technology of new integrative formulation of poria five powder and production method thereof |
| 06/22/2011 | CN102100793A Chinese medicine preparation for treating anemia |
| 06/22/2011 | CN102100792A Preparation technology of new integrative formulation of siwu decoction and production method thereof |
| 06/22/2011 | CN102100773A Low dosage burnet root solid preparation |
| 06/22/2011 | CN102100767A Traditional Chinese medicine composition for treating iron deficiency anemia and preparation method thereof |
| 06/22/2011 | CN102100736A Method for simultaneously extracting water-soluble and lipid-soluble effective components in traditional Chinese medicine salvia miltiorrhiza bunge |
| 06/22/2011 | CN102100712A Method for extracting panax notoginseng saponins by using continuous countercurrent ultrasonic extraction combined film technology |
| 06/22/2011 | CN102100707A Cordyceps sinensis health-care liquor |
| 06/22/2011 | CN101695475B Ozagrel sodium injection and preparation method thereof |
| 06/22/2011 | CN101669904B Epoprostanol lipid nanoparticle and preparation method thereof |
| 06/22/2011 | CN101612316B Application of dendrobium officinale aqueous extract in preparing medicine for preventing and treating hypertension and apoplexy |
| 06/22/2011 | CN101564424B Common lamiophlomis root chewable tablet and preparation thereof |
| 06/22/2011 | CN101411784B Preparation technique of compound oral liquid for tonifying blood containing red skin of peanut |
| 06/22/2011 | CN101264316B Preparation of medicinal protolysate |
| 06/22/2011 | CN101229388B Stanching material (spray, membrane) based on Chinese herbal medicine and preparing method thereof |
| 06/22/2011 | CN101143011B Method for improving iron bioavailability in food |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964581 Use of difructose anhydride-containing composition |
| 06/21/2011 | US7964564 Chimeric natriuretic peptides |
| 06/21/2011 | US7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2199474C Inhibitory or blocking agents of molecular generating and/or inducing functions |
| 06/16/2011 | WO2011072059A1 Use of transferrin in treatment of beta-thalassemias |
| 06/16/2011 | WO2011069336A1 Use of saturated amines compounds in manufacture of medicaments for mobilizing peripheral blood hematopoietic stem cell |
| 06/16/2011 | WO2011047770A3 Pyrazolopyrimidine derivatives |
| 06/16/2011 | US20110144320 N-pyrazole a2a receptor agonists |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144187 Aptamer inhibition of thrombus formation |
| 06/16/2011 | US20110144167 Prolyl Hydroxylase Inhibitors |
| 06/16/2011 | US20110144138 Substituted pyrimido isoquinoline derivatives |
| 06/16/2011 | US20110144132 Substituted pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144131 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144097 2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazin-4-yl)-phenyl]-amides |
| 06/16/2011 | US20110144087 Short acting benzothiazepine calcium channel blockers and uses thereof |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144042 Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative |
| 06/16/2011 | US20110144025 Methods of Reducing Hemorrhage Due to Surgical Procedure |
| 06/16/2011 | US20110144023 Nano Cancer Barrier Device (NCBD) to Immobilize and Inhibit the Division of Metastic Cancer Stem Cells |
| 06/16/2011 | US20110144019 Method of treating chronic heart failure |
| 06/16/2011 | US20110143993 Endothelial basement membrane targeting peptide ligands |
| 06/16/2011 | US20110143992 Methods and Compositions Related to GHS-R Antagonists |
| 06/16/2011 | US20110142937 Methods and Compositions To Treat Hemorrhagic Conditions of The Brain |
| 06/16/2011 | US20110142927 Nanoparticles for protein drug delivery |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142910 Clotting and Healing Compositions Containing Keratin Biomaterials |
| 06/16/2011 | US20110142885 Spray-dried human plasma |
| 06/16/2011 | US20110142884 Materials and Methods for Making Improved Micelle Compositions |
| 06/16/2011 | US20110142839 Treatment of pulmonary edema |
| 06/16/2011 | US20110142812 Suppressive macrophages, c-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic purpura |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142787 Polymerized cyclic nitroxide radical compound and use thereof |
| 06/16/2011 | US20110138888 Treatment of obesity |
| 06/16/2011 | CA2782397A1 Use of transferrin in treatment of beta-thalassemias |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332563A2 Use of BAFF to treat sepsis |
| 06/15/2011 | EP2332535A1 Solid pharmaceutical composition |
| 06/15/2011 | EP2332424A1 Method for producing lipid |